Viewing Study NCT00904059


Ignite Creation Date: 2025-12-24 @ 2:54 PM
Ignite Modification Date: 2026-01-01 @ 8:01 AM
Study NCT ID: NCT00904059
Status: COMPLETED
Last Update Posted: 2011-01-07
First Post: 2009-04-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Drug-Drug Interaction Study in Healthy Subjects
Sponsor: Bristol-Myers Squibb
Organization:

Study Overview

Official Title: Open-Label, Randomized, Multiple-Dose, Drug-Drug Interaction Study to Assess the Pharmacokinetics and Safety of BMS-790052 and BMS-650032 Co-administered in Healthy Subjects
Status: COMPLETED
Status Verified Date: 2010-12
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to assess the pharmacokinetics and safety of BMS-790052 and BMS-650032 when co-administered and when administered alone
Detailed Description: Pharmacokinetics and Safety in Healthy Subjects

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: